에스디바이오센서
137310KOSPI의료용 기기 제조업50.3 / 100
Reference Date: 2026-06-10
Company InformationBased on 2025 Annual Report
Business Overview
SD Biosensor, established in 2010, specializes in in-vitro diagnostics, offering products such as STANDARD Q, STANDARD F, and STANDARD E, which are known for high sensitivity and specificity. These products are used for rapid testing of various diseases, including COVID-19, and hold significant market share globally. The in-vitro diagnostics industry plays a crucial role in disease prevention and public health, with stringent regulations in major countries.
Number of Employees
656people
Average Salary
67.1M KRW
Score Calculation Basis
Detailed Financial Score
Half of industry avg (excellent)
Well below industry avg
1.6x industry avg (risky)
Avg ▲4.1% (2-year basis)
Avg ▲14.2% (2-year basis)
Avg ROE -13.0% (declining, 3yr)
Detailed News Sentiment
- Positive에스디바이오센서, 1분기 흑자 전환…재무안정성 강화
에스디바이오센서가 1분기 흑자 전환을 달성하며 재무 안정성이 크게 강화되었다.
- Positive에스디바이오센서, 올 1분기 순이익 223억 원…”재무 구조 개선”
에스디바이오센서가 분기순이익 흑자 전환과 매출 증가를 통해 재무 구조 개선을 이루어냈다.
- Positive에스디바이오센서, 재무 구조 개선에…분기순이익 흑자 전환
에스디바이오센서의 분기순 이익 흑자 전환으로 재무 구조 개선이 성과로 입증되었다.
Detailed Momentum
Near 52w low (0%, downtrend)
1m -12.05% (falling)
Volume decreasing
Detailed Disclosure
- Neutral기업지배구조보고서공시2026-05-29
- Neutral분기보고서 (2026.03)2026-05-14
